EASD 2019: Semaglutide Reduces HbA1c and Weight More Than Both Canagliflozin in Type 2 Diabetes
Results of the SUSTAIN 8 trial pointed to superior efficacy with semaglutide.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.